BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19074214)

  • 1. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
    Gobbi PG; Corbella F; Valentino F; Bergonzi M; Sangalli C; Perfetti V; Corazza GR
    Ann Oncol; 2009 Mar; 20(3):465-8. PubMed ID: 19074214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
    Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
    Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
    Schmelz R; Miehlke S; Thiede C; Brueckner S; Dawel M; Kuhn M; Ruskoné-Formestraux A; Stolte M; Jentsch C; Hampe J; Morgner A
    J Gastroenterol; 2019 May; 54(5):388-395. PubMed ID: 30327875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma].
    Ghorbal L; Hdiji A; Ben Salah H; Elloumi F; Frikha M; Elloumi M; Daoud J
    Cancer Radiother; 2018 Dec; 22(8):763-766. PubMed ID: 30337049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
    Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
    Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis.
    Xie YL; He CY; Wei SQ; Guan WJ; Jiang Z
    Chin Med J (Engl); 2020 Jun; 133(11):1337-1346. PubMed ID: 32452892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome.
    Diz-Lois Palomares MT; Souto Ruzo J; Yáñez López JA; Alvarez García A; Arnal Monreal F; Vázquez-Iglesias JL
    Rev Esp Enferm Dig; 2002 Nov; 94(11):669-78. PubMed ID: 12690990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
    Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
    J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A
    J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.